New Pill Successfully Lowers Lp(a) Levels

Muvalaplin shows promise in lowering lipoprotein(a) levels, which are genetically determined and confer cardiovascular risk and for which no approved therapies currently exist.
Medscape Medical News

source https://www.medscape.com/viewarticle/new-pill-successfully-lowers-lp-levels-2024a1000l13?src=rss